337 related articles for article (PubMed ID: 7969067)
1. Binding of [3H]KF17837S, a selective adenosine A2 receptor antagonist, to rat brain membranes.
Nonaka H; Mori A; Ichimura M; Shindou T; Yanagawa K; Shimada J; Kase H
Mol Pharmacol; 1994 Nov; 46(5):817-22. PubMed ID: 7969067
[TBL] [Abstract][Full Text] [Related]
2. [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.
Jarvis MF; Schulz R; Hutchison AJ; Do UH; Sills MA; Williams M
J Pharmacol Exp Ther; 1989 Dec; 251(3):888-93. PubMed ID: 2600819
[TBL] [Abstract][Full Text] [Related]
3. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
Dionisotti S; Ongini E; Zocchi C; Kull B; Arslan G; Fredholm BB
Br J Pharmacol; 1997 Jun; 121(3):353-60. PubMed ID: 9179373
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes.
Bruns RF; Lu GH; Pugsley TA
Mol Pharmacol; 1986 Apr; 29(4):331-46. PubMed ID: 3010074
[TBL] [Abstract][Full Text] [Related]
5. Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranes.
Zocchi C; Ongini E; Ferrara S; Baraldi PG; Dionisotti S
Br J Pharmacol; 1996 Apr; 117(7):1381-6. PubMed ID: 8730729
[TBL] [Abstract][Full Text] [Related]
6. KF17837 ((E)-8-(3,4-dimethoxystyryl)-1,3-dipropyl-7-methylxanthine), a potent and selective adenosine A2 receptor antagonist.
Nonaka H; Ichimura M; Takeda M; Nonaka Y; Shimada J; Suzuki F; Yamaguchi K; Kase H
Eur J Pharmacol; 1994 May; 267(3):335-41. PubMed ID: 8088373
[TBL] [Abstract][Full Text] [Related]
7. Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors.
Cunha RA; Johansson B; Constantino MD; Sebastião AM; Fredholm BB
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):261-71. PubMed ID: 8692280
[TBL] [Abstract][Full Text] [Related]
8. Characterization of two affinity states of adenosine A2a receptors with a new radioligand, 2-[2-(4-amino-3-[125I]iodophenyl)ethylamino]adenosine.
Luthin DR; Olsson RA; Thompson RD; Sawmiller DR; Linden J
Mol Pharmacol; 1995 Feb; 47(2):307-13. PubMed ID: 7870039
[TBL] [Abstract][Full Text] [Related]
9. ZM241385 is an antagonist of the facilitatory responses produced by the A2A adenosine receptor agonists CGS21680 and HENECA in the rat hippocampus.
Cunha RA; Constantino MD; Ribeiro JA
Br J Pharmacol; 1997 Dec; 122(7):1279-84. PubMed ID: 9421273
[TBL] [Abstract][Full Text] [Related]
10. Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists.
Maemoto T; Finlayson K; Olverman HJ; Akahane A; Horton RW; Butcher SP
Br J Pharmacol; 1997 Nov; 122(6):1202-8. PubMed ID: 9401787
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a low affinity binding site for N6-substituted adenosine derivatives in rat testis membranes.
Mazzoni MR; Buffoni RS; Giusti L; Lucacchini A
J Recept Signal Transduct Res; 1995; 15(7-8):905-29. PubMed ID: 8673723
[TBL] [Abstract][Full Text] [Related]
12. Binding of [3H]MSX-2 (3-(3-hydroxypropyl)-7-methyl-8-(m-methoxystyryl)-1-propargylxanthine) to rat striatal membranes--a new, selective antagonist radioligand for A(2A) adenosine receptors.
Müller CE; Maurinsh J; Sauer R
Eur J Pharm Sci; 2000; 10(4):259-65. PubMed ID: 10838015
[TBL] [Abstract][Full Text] [Related]
13. A1 and A2 adenosine receptor modulation of contractility in the cauda epididymis of the guinea-pig.
Haynes JM; Alexander SP; Hill SJ
Br J Pharmacol; 1998 Oct; 125(3):570-6. PubMed ID: 9806342
[TBL] [Abstract][Full Text] [Related]
14. Labeling of A2A adenosine receptors in human platelets by use of the new nonxanthine antagonist radioligand [3H]SCH 58261.
Dionisotti S; Ferrara S; Molta C; Zocchi C; Ongini E
J Pharmacol Exp Ther; 1996 Sep; 278(3):1209-14. PubMed ID: 8819504
[TBL] [Abstract][Full Text] [Related]
15. Characterization of human striatal A2-adenosine receptors using radioligand binding and photoaffinity labeling.
Ji XD; Stiles GL; van Galen PJ; Jacobson KA
J Recept Res; 1992; 12(2):149-69. PubMed ID: 1583620
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of a simple behavioral response mediated selectively by central adenosine A1 receptors, using in vivo and in vitro techniques.
Marston HM; Finlayson K; Maemoto T; Olverman HJ; Akahane A; Sharkey J; Butcher SP
J Pharmacol Exp Ther; 1998 Jun; 285(3):1023-30. PubMed ID: 9618404
[TBL] [Abstract][Full Text] [Related]
17. [3H]-SCH 58261 labelling of functional A2A adenosine receptors in human neutrophil membranes.
Varani K; Gessi S; Dionisotti S; Ongini E; Borea PA
Br J Pharmacol; 1998 Apr; 123(8):1723-31. PubMed ID: 9605581
[TBL] [Abstract][Full Text] [Related]
18. Identification of A1 and A2 adenosine receptors in the rat spinal cord.
Choca JI; Proudfit HK; Green RD
J Pharmacol Exp Ther; 1987 Sep; 242(3):905-10. PubMed ID: 3656118
[TBL] [Abstract][Full Text] [Related]
19. 1,3-Dipropyl-8-[2-(5,6-epoxy)norbornyl]xanthine, a potent, specific and selective A1 adenosine receptor antagonist in the guinea pig heart and brain and in DDT1MF-2 cells.
Belardinelli L; Shryock JC; Zhang Y; Scammells PJ; Olsson R; Dennis D; Milner P; Pfister J; Baker SP
J Pharmacol Exp Ther; 1995 Dec; 275(3):1167-76. PubMed ID: 8531078
[TBL] [Abstract][Full Text] [Related]
20. Effect of adenosine and some of its structural analogues on the conductance of NMDA receptor channels in a subset of rat neostriatal neurones.
Nörenberg W; Wirkner K; Illes P
Br J Pharmacol; 1997 Sep; 122(1):71-80. PubMed ID: 9298530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
